Fund structure: ARKK is an actively managed, non-diversified thematic fund targeting disruptive innovation, while SCHD is a passively managed index fund tracking the Dow Jones U.S. Dividend 100 Index. Sector exposure diverges sharply: ARKK concentrates in healthcare, technology, financials, and consumer discretionary; SCHD tilts toward energy, consumer staples, healthcare, and industrials.
INTA (Intapp, Inc.) has delivered notably stronger recent momentum than VC (Visteon Corporation), supported by accelerating subscription revenue growth. VC trades at a lower earnings multiple and offers a dividend, but has been in a pronounced downtrend with weakening sentiment and recent analyst price-target reductions.
Diverging momentum: ASO has posted sharply positive year-to-date relative performance, while DKS has traded lower over the same period amid integration headwinds. Quality of growth differs: ASO's recent profit beat leaned on a one-time tariff refund and share repurchases, whereas DKS retains a healthy core business but is absorbing a difficult Foot Locker turnaround.
ARES is the larger, credit-centric alternative asset manager with roughly $691 billion in assets under management (AUM), versus approximately $346 billion for TPG . ARES raised its quarterly dividend by 20% year over year, while TPG has trimmed its payout in recent quarters.
ASML is the world's sole supplier of extreme ultraviolet (EUV) lithography machines used to make the most advanced chips, giving it a near-monopoly in a critical AI supply-chain bottleneck. MRVL is a fabless (factory-free) chip designer focused on custom AI processors and data-center connectivity, but its stock has been pressured by dilution concerns tied to its large all-stock acquisition.
Different mandates: ARTY is a global, thematic artificial-intelligence and technology fund, while IGV is a North American software-sector fund. Exposure contrast: ARTY skews toward semiconductor and data-center hardware; IGV concentrates in enterprise software, cloud, and cybersecurity.
Both ARCC and GAIN are business development companies (BDCs), which lend to and invest in middle-market U.S. companies and pass most of their income to shareholders as dividends. ARCC is the largest BDC by market capitalization with a broadly diversified portfolio, while GAIN is a smaller, buyout-oriented BDC that combines debt with meaningful equity exposure.
Both ARCC and GBDC are business development companies (BDCs), which lend to U.S. middle-market businesses and distribute most of their income to shareholders, giving both stocks double-digit dividend yields. ARCC is the largest publicly traded BDC by market capitalization, offering meaningful scale and diversification advantages over the smaller GBDC .
AOR and AVMA are both diversified "fund of funds" asset-allocation ETFs, but they pursue the same goal through fundamentally different methods: AOR is a low-cost passive index strategy, while AVMA is an actively managed, factor-tilted portfolio. Cost structure is a clear differentiator: AOR charges a 0.15% net expense ratio versus AVMA's 0.21%, a meaningful gap for long-term buy-and-hold investors.
AOR is a globally diversified "fund of funds" targeting roughly an 80% equity / 20% fixed-income allocation, while SPY is a pure U.S. large-cap equity fund tracking the S&P 500 Index. SPY carries a lower expense ratio (about 0.09%) than AOR (0.15% net), reflecting its simpler single-index construction.
AOA is a fund-of-funds "aggressive allocation" portfolio targeting roughly 80% global equities and 20% fixed income, while IVV is a pure large-cap U.S. equity fund tracking the S&P 500. Cost structure diverges sharply: IVV charges a 0.03% expense ratio versus AOA 's 0.15% net expense ratio.
Both AZN and BMY are large-cap pharmaceutical leaders, but their recent quarters point in different directions on earnings momentum. AZN beat revenue and profit estimates, reaffirmed its full-year guidance, and raised its dividend, fueling a sharp rebound in its share price.
NEM is the world's largest gold producer and, with a lower all-in sustaining cost (AISC) of roughly $1,520 per ounce, holds a wider profit margin over cost than AU . AU delivered record free cash flow and dividends plus a $2 billion buyback, but third-quarter production fell about 9% while AISC climbed to approximately $2,170 per ounce.
AWK is the largest publicly traded U.S. water and wastewater utility, with a roughly $30 billion market capitalization and a 7%–9% long-term EPS (earnings per share) and dividend growth target. HTO (H2O America) is a smaller, faster-growing water utility that is expanding aggressively into Texas, but is currently absorbing share dilution that has pressured per-share results.
Bank of America ( BAC ) is re-accelerating on record net interest income, a rebound in investment banking, and a clear path to higher returns on capital. Royal Bank of Canada ( RY ) has delivered stronger recent momentum and consistent dividend growth, supported by dominant Canadian market share and a diversified earnings base.
Banco Bradesco ( BBD ) is one of Brazil's largest private banks, trading near its 52-week low after a sharp pullback in recent weeks, while Mizuho Financial Group ( MFG ) is a Japanese megabank that has risen strongly over the past year before cooling recently. Both are financial-sector American Depositary Receipts (ADRs — U.S.-listed securities representing foreign shares), but they carry very different risk profiles, valuation levels, and market positioning.
AVEM and DFAE are both actively managed, broadly diversified emerging-markets equity ETFs, but they differ meaningfully in breadth, factor emphasis, and concentration. AVEM holds roughly 4,000 stocks with a more pronounced tilt toward value and profitability, plus heavier semiconductor and technology exposure.
Strategy differs fundamentally: AVNM is an actively managed fund of funds with a value and small-cap tilt, while VEU is a passive, market-cap-weighted index tracker. Cost gap is wide: VEU charges just 0.04% annually versus 0.31% for AVNM, a structural advantage VEU holds over long holding periods.
AVLV is an actively managed U.S. large-cap value fund holding roughly 270–300 stocks, while VFLO is a rules-based index fund concentrated in about 50–52 free-cash-flow-rich names. AVLV leans into financials, energy, and industrials with a 0.15% expense ratio; VFLO tilts toward technology, energy, and healthcare at a higher 0.39% cost.
Strategy divide: AVNM is an actively managed "fund of funds" that blends value, small-cap, and profitability tilts, while VEA is a low-cost passive index fund tracking developed markets outside the U.S. Exposure difference: AVNM includes a meaningful emerging-markets allocation, whereas VEA is strictly developed-markets ex-U.S. and excludes countries such as China, Taiwan, and India.